These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Development of membrane-active peptide therapeutics in oncology. Chen CH; Zan B; Ulmschneider JP; Wimley WC; Lu TK; Ulmschneider MB; Zhou L J Pept Sci; 2023 Aug; 29(8):e3482. PubMed ID: 36739581 [TBL] [Abstract][Full Text] [Related]
5. Therapeutic peptides: Historical perspectives, current development trends, and future directions. Lau JL; Dunn MK Bioorg Med Chem; 2018 Jun; 26(10):2700-2707. PubMed ID: 28720325 [TBL] [Abstract][Full Text] [Related]
6. Bioconjugation - using selective chemistry to enhance the properties of proteins and peptides as therapeutics and carriers. Gunnoo SB; Madder A Org Biomol Chem; 2016 Sep; 14(34):8002-13. PubMed ID: 27461374 [TBL] [Abstract][Full Text] [Related]
7. Pathogen-derived peptides in drug targeting and its therapeutic approach. Mun SJ; Cho E; Kim JS; Yang CS J Control Release; 2022 Oct; 350():716-733. PubMed ID: 36030988 [TBL] [Abstract][Full Text] [Related]
8. Peptide chemistry toolbox - Transforming natural peptides into peptide therapeutics. Erak M; Bellmann-Sickert K; Els-Heindl S; Beck-Sickinger AG Bioorg Med Chem; 2018 Jun; 26(10):2759-2765. PubMed ID: 29395804 [TBL] [Abstract][Full Text] [Related]
9. Modulating protein-protein interactions: the potential of peptides. Nevola L; Giralt E Chem Commun (Camb); 2015 Feb; 51(16):3302-15. PubMed ID: 25578807 [TBL] [Abstract][Full Text] [Related]
10. Disulfide-constrained peptide scaffolds enable a robust peptide-therapeutic discovery platform. Zhou L; Cai F; Li Y; Gao X; Wei Y; Fedorova A; Kirchhofer D; Hannoush RN; Zhang Y PLoS One; 2024; 19(3):e0300135. PubMed ID: 38547109 [TBL] [Abstract][Full Text] [Related]
11. Potential Active Marine Peptides as Anti-Aging Drugs or Drug Candidates. Yang H; Zhang Q; Zhang B; Zhao Y; Wang N Mar Drugs; 2023 Feb; 21(3):. PubMed ID: 36976193 [TBL] [Abstract][Full Text] [Related]
12. Venom peptides as therapeutics: advances, challenges and the future of venom-peptide discovery. Robinson SD; Undheim EAB; Ueberheide B; King GF Expert Rev Proteomics; 2017 Oct; 14(10):931-939. PubMed ID: 28879805 [TBL] [Abstract][Full Text] [Related]
13. The Potential of the Cyclotide Scaffold for Drug Development. Camarero JA; Campbell MJ Biomedicines; 2019 Apr; 7(2):. PubMed ID: 31010257 [TBL] [Abstract][Full Text] [Related]
14. Is phage display technology on target for developing peptide-based cancer drugs? Landon LA; Zou J; Deutscher SL Curr Drug Discov Technol; 2004 Jun; 1(2):113-32. PubMed ID: 16472251 [TBL] [Abstract][Full Text] [Related]
15. Cyclotides: a patent review. Smith AB; Daly NL; Craik DJ Expert Opin Ther Pat; 2011 Nov; 21(11):1657-72. PubMed ID: 22017409 [TBL] [Abstract][Full Text] [Related]
16. Building on Success: A Bright Future for Peptide Therapeutics. Angell Y; Holford M; Moos WH Protein Pept Lett; 2018; 25(12):1044-1050. PubMed ID: 30430932 [TBL] [Abstract][Full Text] [Related]
17. Advances in venom peptide drug discovery: where are we at and where are we heading? Smallwood TB; Clark RJ Expert Opin Drug Discov; 2021 Oct; 16(10):1163-1173. PubMed ID: 33914674 [No Abstract] [Full Text] [Related]
18. Future directions for peptide therapeutics development. Kaspar AA; Reichert JM Drug Discov Today; 2013 Sep; 18(17-18):807-17. PubMed ID: 23726889 [TBL] [Abstract][Full Text] [Related]
19. Development of JNK2-selective peptide inhibitors that inhibit breast cancer cell migration. Kaoud TS; Mitra S; Lee S; Taliaferro J; Cantrell M; Linse KD; Van Den Berg CL; Dalby KN ACS Chem Biol; 2011 Jun; 6(6):658-66. PubMed ID: 21438496 [TBL] [Abstract][Full Text] [Related]
20. The discovery and maturation of peptide biologics targeting the small G-protein Cdc42: A bioblockade for Ras-driven signaling. Tetley GJN; Murphy NP; Bonetto S; Ivanova-Berndt G; Revell J; Mott HR; Cooley RN; Owen D J Biol Chem; 2020 Feb; 295(9):2866-2884. PubMed ID: 31959628 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]